Healthcare - Biotechnology - NASDAQ - US
$ 10.68
2.69 %
$ 212 M
Market Cap
-1.94
P/E
CASH FLOW STATEMENT
-19.4 M
OPERATING CASH FLOW
-179 K
INVESTING CASH FLOW
68 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Benitec Biopharma Inc.
| Net Income | -21.8 M |
| Depreciation & Amortization | 343 K |
| Capital Expenditures | -179 K |
| Stock-Based Compensation | 830 K |
| Change in Working Capital | 1.17 M |
| Others | 234 K |
| Free Cash Flow | -19.6 M |
Cash Flow
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | Jun-2019 | Jun-2018 | Jun-2017 | Jun-2016 | Jun-2015 | Jun-2014 | Jun-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (21.8) | (19.6) | (18.2) | (13.9) | (8.3) | 2.6 | (8.6) | (4.4) | (18.5) | (8.8) | (10.8) | (6.4) |
| Depreciation & Amortization | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.2 | 0 | 0.2 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | (0.7) | 0 | 0 | 0 | (1.0) | 0 | (0.8) | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.8 | 0.5 | 0.9 | 0.6 | 0.2 | 1.0 | 0 | 0.4 | 0 | 0 | 0 | 0 |
| Other Operating Activities | 1 K | 0.7 | 10 K | 16 K | 2 K | 0.7 | 0 | (4.5) | (1.7) | (0.9) | 1.1 | (2.8) |
| Change in Working Capital | 1.2 | 0.7 | 1.0 | 8 K | 0.1 | 1.3 | 0 | 0.8 | 0 | 0 | 0 | 0 |
| Cash From Operations | (19.4) | (18.0) | (15.9) | (12.8) | (7.5) | 4.8 | (8.6) | (8.3) | (20.2) | (9.7) | (9.7) | (9.3) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (0.2) | 1 K | 13 K | (0.2) | 95 K | (0.4) | 61 K | (0.1) | (0.3) | (0.4) | (0.5) | 29.2 K |
| Other Items | 0 | 0 | 0 | 0 | 1 K | 4.2 K | 47 K | (0.1) | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (0.2) | 1 K | 13 K | (0.2) | 94 K | (0.4) | (0.1) | (0.2) | (0.3) | (0.4) | (0.5) | 29.2 K |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (5.9) | (1.9) | 0 | (3.2) | (0.5) | (0.7) | (0.2) | 1.7 | 3.0 | (0.3) | (0.3) | 0 |
| Cash From Financing Activities | 68.0 | 16.0 | 0 | 22.5 | 1.8 | (0.7) | 6.2 | 6.1 | 17.5 | 39.9 K | 49 K | 35.7 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 48.4 | (1.6) | (15.7) | 10.0 | (5.9) | 4.4 | (0.9) | (0.7) | (2.7) | (7.3) | (9.0) | 27.2 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (19.6) | (18.0) | (15.9) | (13.1) | (7.6) | 4.4 | (8.6) | (8.4) | (20.5) | (10.1) | (10.2) | (9.3) |